(Q35218774)

7 August 2017

title

Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable? (English)

1 reference

7 August 2017

1 reference

Brian Shuch

1

1 reference

7 August 2017

Jonathan Said

2

1 reference

7 August 2017

Jeff C La Rochelle

3

1 reference

7 August 2017

Ying Zhou

4

1 reference

7 August 2017

Gang Li

5

1 reference

7 August 2017

Tobias Klatte

6

1 reference

7 August 2017

Fairooz F Kabbinaavar

7

1 reference

7 August 2017

Allan J Pantuck

8

1 reference

7 August 2017

Arie S Belldegrun

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

16 September 2009

1 reference

7 August 2017

1 reference

7 August 2017

volume

182

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

2164-2171

1 reference

Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

A molecular classification of papillary renal cell carcinoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

The Heidelberg classification of renal cell tumours.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. 3.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Sarcomatoid renal cell carcinoma. A treatable entity

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Front-line weekly chemotherapy with gemcitabine for unfit patients with non-small cell lung cancer (NSCLC).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3175230

Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases

26 September 2018

1 reference

12 December 2020

Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma

1 reference

12 December 2020

Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome

1 reference

12 December 2020

Sarcomatoid renal carcinoma

1 reference

12 December 2020

Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases

1 reference

12 December 2020

Sarcomatoid carcinoma of the kidney

1 reference

12 December 2020

Cytoreductive surgery for stage IV renal cell carcinoma

1 reference

12 December 2020

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

12 December 2020

Nephrectomy before interleukin-2 therapy for patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma

1 reference

12 December 2020

10.1016/J.JURO.2009.07.049

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference